Since these findings suggest the suppressive activity of CUR on IκKβ action in the salivary cells of individuals with HNSCC, it has been suggested that IκKβ can be considered as a biomarker for identifying the activity of CUR in head and neck cancer [186]. This evidence concerns the gene IKBKB and head and neck cancer.